About Us
Sprectroo is a subsidiary of Ailynix that has created a AI-Driven Drug Derivatization and Repurposing Platform that incorporates Deep Learning, Blockchain and Genomics.
Mission
Given the high attrition rates, substantial costs and slow pace of new drug discovery and development, repurposing of 'old' drugs to treat both common and rare diseases is increasingly becoming an attractive proposition. It’s the vision of Sprectroo Founding Team to collaborate with international Pharma and Biotechnology companies identifying promising candidate drugs,
Definition
Drug Repurposing is a strategy for identifying new uses for approved or investigational drugs that are outside the scope of the original medical indication.
Drug Derivatization is a technique used in chemistry which transforms a chemical compound into a product of similar chemical structure, called a derivative.
Drug repositioning for personalized medicine
Human diseases can be caused by complex mechanisms involving aberrations in numerous proteins and pathways. With recent advances in genomics, elucidating the molecular basis of disease on a personalized level has become an attainable goal. In many cases, relevant molecular targets will be identified for which approved drugs already exist, and the potential
Platform
AIDRRP is a Genomics Driven Drug Derivatization and Repositioning
Platform that implements Deep Learning, (DL) with Blockchain and
Genomics de novo design technology called "derivatization design and
discovery" that applies artificial-intelligence-assisted forward in
Silico synthesis for the generation of near neighbor lead analogues as well
as scaffold variations.
The several attractive features of the methodology include synthetic
feasibility, reagent availability and cost data associated with each new
molecule; thus, detailed synthetic assessment is automatically generated
during the design.
Core Technologies/Features
Integrated Platform, Innovative Solutions
Chemical derivatization for the analysis of drugs
Integrated theoretical & experimental data
Integrated Genomic data
Developing and evaluating primary and secondary screening tests
Generating series of small molecules targeting novel mechanisms of action
Modulating therapeutic targets to induce specific biological responses
OUR FOCUS
Collaborate with North American Pharma and Bio-Pharma companies through equity and/or cooperative Joint Venture partnerships focusing on drug derivatization and repurposing of approved and failed drugs.
Collaborate with Asia’s Pharma and Bio-Pharma companies through equity and/or cooperative Joint Venture partnerships focusing on drug derivatization of approved and failed drugs.
Collaborate with European and South African Pharma and Bio-Pharma companies through equity and/or cooperative Joint Venture partnerships focusing on drug derivatization and repurposing of approved and failed drugs.
PARTNERS
A global company with operations across Asia, Europe, and North America, WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable global pharmaceutical and healthcare industry to advance discoveries and deliver groundbreaking treatments to patients.